MeiraGTx Holdings plc (MGTX) |
|
13.53 0.44 (3.36%)
|
09-20 00:09 |
|
Open: |
13.29 |
Pre. Close: |
13.09 |
|
High:
|
13.64 |
Low:
|
12.62 |
|
Volume:
|
187,309 |
Market Cap:
|
506M |
|
|
|
|
MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. The company is headquartered in New York, New York and currently employs 130 full-time employees. The firm develops gene therapy treatments for a range of inherited and acquired disorders. The company is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). The company is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. The company is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, A006, AAV-AQP1 and AAV-UPF1. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
13.653 - 13.719 |
13.719 - 13.776 |
|
Low:
|
12.47 - 12.542 |
12.542 - 12.605 |
|
Close:
|
13.415 - 13.534 |
13.534 - 13.636 |
|
Technical analysis |
as of: 2020-09-18 4:33:19 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 17.25 One year: 20.15 |
| Support: |
Support1: 13.06 Support2: 12.01 |
| Resistance: |
Resistance1: 14.77 Resistance2: 17.25 |
| Pivot: |
13.01 |
| Moving Average: |
MA(5): 13.34 MA(20): 13.14 
MA(100): 13.65 MA(250): 15.37 |
| MACD: |
MACD(12,26): -0.04 Signal(9): -0.10 |
| Stochastic oscillator: |
%K(14,3): 50.85 %D(3): 54.02 |
| RSI: |
RSI(14): 53.23 |
| 52-week: |
High: 22.32 Low: 8.82 Change(%): -26.1 |
| Average Vol(K): |
3-Month: 12644 10-Days: 20523 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.MGTX has closed below upper band by 10.9%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to MGTX's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 17 Sep 2020
MeiraGTx Holdings plc [MGTX] Revenue clocked in at $17.20 million, down -31.97% YTD: What’s Next? - The DBT News
Thu, 17 Sep 2020
After A -31.97% Fall This Year Is MeiraGTx Holdings plc (NASDAQ:MGTX) A Better Buy Than Others? - Marketing Sentinel
Wed, 16 Sep 2020
MeiraGTx Holdings plc [MGTX] Is Still Undervalued at $13.91 - mzpnews.com
Wed, 16 Sep 2020
MeiraGTx Holdings plc (NASDAQ:MGTX) Is a Buzzing Hot Stock - Stocks Register
Wed, 16 Sep 2020
Do Analysts Expect MeiraGTx Holdings PLC (MGTX) Stock to Rise? - InvestorsObserver
Wed, 16 Sep 2020
MeiraGTx (NASDAQ:MGTX) Research Coverage Started at BofA Securities - MarketBeat
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
37 |
| Shares Float (M) |
15 |
|
% Held by Insiders
|
33.79 |
|
% Held by Institutions
|
47.17 |
|
Shares Short (K)
|
427 |
|
Shares Short P. Month (K)
|
453 |
Stock Financials |
|
EPS
|
-1.580 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
4.620 |
|
Profit Margin
|
|
|
Operating Margin
|
-332.71 |
|
Return on Assets (ttm)
|
-13.2 |
|
Return on Equity (ttm)
|
-37.7 |
|
Qtrly Rev. Growth
|
24.8 |
|
Gross Profit (p.s.)
|
0.356 |
|
Sales Per Share
|
0.461 |
|
EBITDA (p.s.)
|
-1.453 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-66 |
|
Levered Free Cash Flow (M)
|
-54 |
Stock Valuations |
|
PE Ratio
|
-8.56 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.93 |
|
Price to Sales
|
29.37 |
|
Price to Cash Flow
|
-7.70 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
